81 related articles for article (PubMed ID: 30506157)
1. Uterotonic Drugs for the Prevention of Postpartum Haemorrhage: A Cost-Effectiveness Analysis.
Pickering K; Gallos ID; Williams H; Price MJ; Merriel A; Lissauer D; Tobias A; Hofmeyr GJ; Coomarasamy A; Roberts TE
Pharmacoecon Open; 2019 Jun; 3(2):163-176. PubMed ID: 30506157
[TBL] [Abstract][Full Text] [Related]
2. Current research on carbetocin and implications for prevention of postpartum haemorrhage.
Theunissen FJ; Chinery L; Pujar YV
Reprod Health; 2018 Jun; 15(Suppl 1):94. PubMed ID: 29945640
[TBL] [Abstract][Full Text] [Related]
3. A cost-effectiveness analysis of early detection and bundled treatment of postpartum hemorrhage alongside the E-MOTIVE trial.
Williams EV; Goranitis I; Oppong R; Perry SJ; Devall AJ; Martin JT; Mammoliti KM; Beeson LE; Sindhu KN; Galadanci H; Alwy Al-Beity F; Qureshi Z; Hofmeyr GJ; Moran N; Fawcus S; Mandondo S; Middleton L; Hemming K; Oladapo OT; Gallos ID; Coomarasamy A; Roberts TE
Nat Med; 2024 Jun; ():. PubMed ID: 38844798
[TBL] [Abstract][Full Text] [Related]
4. Uterotonics in elective caesarean delivery: a randomised non-inferiority study comparing carbetocin 20 μg and 100 μg.
Tabl S; Balki M; Downey K; Tomlinson G; Farine D; Seaward G; Carvalho JCA
Anaesthesia; 2019 Feb; 74(2):190-196. PubMed ID: 30506558
[TBL] [Abstract][Full Text] [Related]
5. Uterotonic drugs to prevent postpartum haemorrhage: a network meta-analysis.
Gallos I; Williams H; Price M; Pickering K; Merriel A; Tobias A; Lissauer D; Gee H; Tunçalp Ö; Gyte G; Moorthy V; Roberts T; Deeks J; Hofmeyr J; Gülmezoglu M; Coomarasamy A
Health Technol Assess; 2019 Feb; 23(9):1-356. PubMed ID: 30821683
[TBL] [Abstract][Full Text] [Related]
6. Intramuscular oxytocin versus oxytocin/ergometrine versus carbetocin for prevention of primary postpartum haemorrhage after vaginal birth: study protocol for a randomised controlled trial (the IMox study).
van der Nelson H; O'Brien S; Lenguerrand E; Marques E; Alvarez M; Mayer M; Burnard S; Siassakos D; Draycott T
Trials; 2019 Jan; 20(1):4. PubMed ID: 30606246
[TBL] [Abstract][Full Text] [Related]
7. Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis.
Gallos ID; Papadopoulou A; Man R; Athanasopoulos N; Tobias A; Price MJ; Williams MJ; Diaz V; Pasquale J; Chamillard M; Widmer M; Tunçalp Ö; Hofmeyr GJ; Althabe F; Gülmezoglu AM; Vogel JP; Oladapo OT; Coomarasamy A
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011689. PubMed ID: 30569545
[TBL] [Abstract][Full Text] [Related]
8. Uterotonic agents for first-line treatment of postpartum haemorrhage: a network meta-analysis.
Parry Smith WR; Papadopoulou A; Thomas E; Tobias A; Price MJ; Meher S; Alfirevic Z; Weeks AD; Hofmeyr GJ; Gülmezoglu AM; Widmer M; Oladapo OT; Vogel JP; Althabe F; Coomarasamy A; Gallos ID
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD012754. PubMed ID: 33232518
[TBL] [Abstract][Full Text] [Related]
9. Oxytocin quality: evidence to support updated global recommendations on oxytocin for postpartum hemorrhage.
Lambert P; McIntosh MP; Widmer M; Evans L; Rauscher M; Kuwana R; Theunissen F; Yeager B; Petach H
J Pharm Policy Pract; 2020; 13():14. PubMed ID: 32467764
[TBL] [Abstract][Full Text] [Related]
10. A systematic review of the cost-effectiveness of uterotonic agents for the prevention of postpartum hemorrhage.
Lawrie TA; Rogozińska E; Sobiesuo P; Vogel JP; Ternent L; Oladapo OT
Int J Gynaecol Obstet; 2019 Jul; 146(1):56-64. PubMed ID: 31049950
[TBL] [Abstract][Full Text] [Related]
11. How do I manage severe postpartum hemorrhage?
Butwick A; Lyell D; Goodnough L
Transfusion; 2020 May; 60(5):897-907. PubMed ID: 32319687
[TBL] [Abstract][Full Text] [Related]
12. International consensus statement on the use of uterotonic agents during caesarean section.
Heesen M; Carvalho B; Carvalho JCA; Duvekot JJ; Dyer RA; Lucas DN; McDonnell N; Orbach-Zinger S; Kinsella SM
Anaesthesia; 2019 Oct; 74(10):1305-1319. PubMed ID: 31347151
[TBL] [Abstract][Full Text] [Related]
13. Tranexamic acid for post-partum haemorrhage: What, who and when.
Brenner A; Ker K; Shakur-Still H; Roberts I
Best Pract Res Clin Obstet Gynaecol; 2019 Nov; 61():66-74. PubMed ID: 31128974
[TBL] [Abstract][Full Text] [Related]
14. Thromboprophylaxis during pregnancy and the puerperium: a systematic review and economic evaluation to estimate the value of future research.
Davis S; Pandor A; Sampson FC; Hamilton J; Nelson-Piercy C; Hunt BJ; Daru J; Goodacre S; Carser R; Rooney G; Clowes M
Health Technol Assess; 2024 Mar; 28(9):1-176. PubMed ID: 38476084
[TBL] [Abstract][Full Text] [Related]
15. New-onset movement disorder in the immediate postpartum period.
Wikeley S; Bacon I; Greer O; Evans M; Hasan R; Pathak S
BMJ Case Rep; 2023 Dec; 16(12):. PubMed ID: 38154870
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness and budget impact of heat-stable carbetocin compared to oxytocin and misoprostol for the prevention of postpartum hemorrhage (PPH) in women giving birth in India.
Cook JR; Saxena K; Taylor C; Jacobs JL
BMC Health Serv Res; 2023 Mar; 23(1):267. PubMed ID: 36932411
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness analysis of carbetocin for prevention of postpartum hemorrhage in a low-burden high-resource city of China.
You JHS; Leung TY
PLoS One; 2022; 17(12):e0279130. PubMed ID: 36520799
[TBL] [Abstract][Full Text] [Related]
18. What is the Economic Cost of Providing an All Wales Postpartum Haemorrhage Quality Improvement Initiative (OBS Cymru)? A Cost-Consequences Comparison with Standard Care.
Dale M; Bell SF; O'Connell S; Scarr C; James K; John M; Collis RE; Collins PW; Carolan-Rees G
Pharmacoecon Open; 2022 Nov; 6(6):847-857. PubMed ID: 36066836
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of inhaled oxytocin for prevention of postpartum haemorrhage: a modelling study applied to two high burden settings.
Carvalho N; Hoque ME; Oliver VL; Byrne A; Kermode M; Lambert P; McIntosh MP; Morgan A
BMC Med; 2020 Jul; 18(1):201. PubMed ID: 32718336
[TBL] [Abstract][Full Text] [Related]
20. A Comparative Study of Vaginal Labor and Caesarean Section Postpartum Uterine Myoelectrical Activity.
Diaz-Martinez A; Mas-Cabo J; Prats-Boluda G; Garcia-Casado J; Cardona-Urrego K; Monfort-Ortiz R; Lopez-Corral A; De Arriba-Garcia M; Perales A; Ye-Lin Y
Sensors (Basel); 2020 May; 20(11):. PubMed ID: 32466584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
